Effect of lapatinib plus capecitabine (L+C) on quality of life (QOL) compared to capecitabine (C) alone in ErbB2+ metastatic breast cancer (MBC): An exploratory analysis
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: X. Zhou, A. Segreti, D. Cameron, C. E. Geyer, D. Cella, M. Amonkar, S. Stein, M. D. Walker
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2266018910